• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Negative Pressure Weighing Booth for Clean Room Environment
Phosphatidylserine Bulk Purchase for Health and Wellness Industries
Premium Fructooligosaccharide Powder for Food Sweeteners
China Supply Crystalline Fructose for Food Additive Solutions
High Quality Yeast Beta Glucan for Health & Beauty Applications
Carfilzomib

Maharashtra to procure 10,000 vials of remdesivir: Rajesh Tope

expresspharmaJune 08, 2020

Tag: Remdesivir , Maharashtra , coronavirus , COVID-19

The Maharashtra government will procure 10,000 vials of the drug Remdesivir for treating coronavirus patients, informed Rajesh Tope, Public Health Minister.

The expensive medicine is being made available for the poor and needy patients in the state, he said.

“GoM to procure 10k vials of remdesivir. Based on evidence from laboratory, animal and clinical studies, it has generated promising results in MERS-CoV and SARS which are also caused by coronavirus,” Tope tweeted.

“WHO suggests it may have some positive effects on COVID-19 treatment. This expensive medicine is being made available for poor & needy patients,” he added.


Previous:Ministry of Health publishes draft New Drugs and Clinical Trials (Amendment) Rules

Next:Shanghai Junshi Biosciences starts human tests for coronavirus antibody drug

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

Maharashtra to procure 10,000 vials of remdesivir: Rajesh Tope | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

You may like
More>>

Remdesivir Intermediate

Remdesivir Intermediate
Remdesivir

Remdesivir
Remdesivir Impurity 6

Remdesivir Impurity 6
Remdesivir amino ester compound

Remdesivir amino ester compound
REMDESIVIR

REMDESIVIR
Remdesivir

Remdesivir
SARS-CoV-2 (COVID-19) IgM/IgG ANTIBODY FAST DETECTION KIT (COLLOIDAL GOLD)

SARS-CoV-2 (COVID-19) IgM/IgG ANTIBODY FAST DETECTION KIT (COLLOIDAL GOLD)
Remdesivir impurity 21

Remdesivir impurity 21
Remdesivir N-4 intermediate

Remdesivir N-4 intermediate
Remdesivir

Remdesivir

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service